Patients Stopping Anti-Obesity Injections Put On Weight Far More Rapidly Than Dieters
Fresh analysis reveals that individuals who stop using new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who end traditional lifestyle programs.
Findings released in a leading health publication points out that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications should be informed of the risk of fast weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight within about a year and a half.
Comparing Approaches
The research, which examined dozens of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
The team note that people who shed pounds through diet and exercise typically see a less rapid weight regain—around 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Experts propose the mechanism of the jabs explains the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making overeating far more likely."
A Chronic Condition?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals argue that, considering the high risk of weight regain, the treatment should be considered life-long.
This perspective is supported by drug manufacturers, who say that the results "emphasize the chronic nature of excess weight," comparing it to managing diseases like diabetes.
Patient Testimonies
Users who have stopped the jabs report a powerful resurgence of cravings.
"It felt as if something flipping and you become starving," said an individual.
The struggle is worsened if individuals have not adopted permanent dietary or behavioural modifications during therapy.
Widespread Use
Figures indicate that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among women compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits relies on ongoing behavioural support.
